Trang chủ

Tài liệu nghiên cứu Y học

Search Journal

Search Article

Search by Auth

Category

From

To

Lung Cancer

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board/Aims and Scope

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

1. Editorial Board

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

2. Contents

Tác giả

3. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer

Tác giả

Seong Yong Park, Go Eun Byun, Chang Young Lee, Jin Gu Lee, Kyoung Young Chung.

3. Immune checkpoint blockade in small cell lung cancer

Tác giả

Rebecca Y. Tay, David Heigener, Martin Reck, Raffaele Califano.

3. Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society

Tác giả

Pathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, Chong Kin Liam, Lye Mun Tho.

3. I love my dog

Tác giả

M. Muller, P. Baas.

3. CT screening for lung cancer: Are we ready to implement in Europe?

Tác giả

Haval Balata, Matthew Evison, Anna Sharman, Philip Crosbie, Richard Booton.

3. Inhibition of the Hedgehog pathway in lung cancer

Tác giả

A. Dimou, A. Bamias, H. Gogas, K. Syrigos.

3. The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group

Tác giả

Robert M MacRae, Miranda Ashton, Olivia Lauk, Wesley Wilson, Andreas Rimner.

3. Lung cancer survivors and employment: A systematic review

Tác giả

Flora Vayr, Frédéric Savall, Laurence Bigay-Game, Jean-Marc Soulat, Fabrice Herin.

3. Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

Tác giả

Samuel G. Armato, Roslyn J. Francis, Sharyn I. Katz, Guntulu Ak, Ashish Gupta.

3. Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

Tác giả

Lizza E.L. Hendriks, Anne-Marie C. Dingemans.

3. Interest in lifestyle advice at lung cancer screening: Determinants and preferences

Tác giả

Claire Stevens, Samuel G. Smith, Samantha L Quaife, Charlotte Vrinten, Rebecca J. Beeken.

3. Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case

Tác giả

Elisa Roca, Marta Pozzari, William Vermi, Valeria Tovazzi, Alfredo Berruti.

4. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer

Tác giả

Bryan J. Ager, Stacey M. Wells, Joshua D. Gruhl, Gregory J. Stoddard, Ying J. Hitchcock.

4. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Tác giả

Ana C.Z. Gelatti, Alexander Drilon, Fernando C. Santini.

4. PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer

Tác giả

Gang Wang, Diana N. Ionescu, Cheng-Han Lee, Tadaaki Hiruki, Chen Zhou.

4. Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression

Tác giả

Evgeny V. Denisov, Anastasia A. Schegoleva, Polina A. Gervas, Anastasia A. Ponomaryova, Vladimir M. Perelmuter.

4. Endobronchial and surgical treatment of pulmonary carcinoid tumors: A systematic literature review

Tác giả

E.M.B.P. Reuling, C. Dickhoff, P.W. Plaisier, H.J. Bonjer, J.M.A. Daniels.

4. Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody

Tác giả

Masafumi Saiki, Takahiro Yoshizawa, Yosuke Dotsu, Ryo Ariyasu, Makoto Nishio.

4. Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Tác giả

Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, Masao Ichiki, Kenji Sugio.

4. Treatment, no treatment and early death in Danish stage I lung cancer patients

Tác giả

Niels Lyhne Christensen, Susanne Dalton, Jesper Ravn, Jane Christensen, Torben Riis Rasmussen.

4. CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome

Tác giả

Sai-Hong Ignatius Ou, Viola W. Zhu.

4. Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC)

Tác giả

Nicolaus Andratschke, Johannes Kraft, Carsten Nieder, Rebecca Tay, Matthias Guckenberger.

4. Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation

Tác giả

Xiangtao Yan, Huijuan Wang, Peng Li, Guowei Zhang, Zhiyong Ma.

4. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

Tác giả

David B. Chapel, Andrew Churg, Eric Santoni-Rugiu, Tohru Tsujimura, Aliya N. Husain.

5. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Tác giả

E. Thunnissen, B.I. Lissenberg-Witte, M.M. van den Heuvel, K. Monkhorst, E.F. Smit.

5. Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Tác giả

Nicolas Guibert, Greg Jones, John F. Beeler, Vincent Plagnol, Julien Mazieres.

5. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations

Tác giả

Wenjie Tang, Xiaolin Li, Xueqi Xie, Xindong Sun, Peng Xie.

5. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features

Tác giả

Mohammadhadi Khorrami, Prantesh Jain, Kaustav Bera, Mehdi Alilou, Anant Madabhushi.

5. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

Tác giả

Urania Dafni, Zoi Tsourti, Katerina Vervita, Solange Peters.

5. First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials

Tác giả

Martin Schuler, Luis Paz-Ares, Lecia V. Sequist, Vera Hirsh, James Chih-Hsin Yang.

5. High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors

Tác giả

Guk Jin Lee, Heejung Lee, In Sook Woo, Taejung Kim, Jin-Hyoung Kang.

5. Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer

Tác giả

Maurice Pérol, Katherine B. Winfree, Gebra Cuyun Carter, Zhanglin Lin Cui, Edward B. Garon.

5. Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Tác giả

Yasuto Yoneshima, Kentaro Tanaka, Yoshimasa Shiraishi, Kojiro Hata, Isamu Okamoto.

5. Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer

Tác giả

Rachel E. Gemine, Robin Ghosal, Gareth Collier, Diane Parry, Keir E. Lewis.

5. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial–mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma

Tác giả

Shinya Neri, Toshi Menju, Terumasa Sowa, Yojiro Yutaka, Hiroshi Date.

5. Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)

Tác giả

Licun Wu, Irene Dell'Anno, Moshe Lapidot, Yoshitaka Sekido, Marc de Perrot.

6. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging sys

Tác giả

Georgios Stamatis, Gunda Leschber, Birte Schwarz, Diana Lütke Brintrup, Karl-Heinz Jöckel.

6. A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer

Tác giả

Hua Cheng, Xiao-Jian Li, Xiao-Jin Wang, Zuo-Wen Chen, Qing-Dong Cao.

6. The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma

Tác giả

Youngjoo Lee, Jae Hyun Jeon, Sung-Ho Goh, Hanseong Roh, Ji-Youn Han.

6. Residential radon, genetic polymorphisms in DNA damage and repair-related

Tác giả

María Lorenzo-González, Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Juan M. Barros-Dios.

6. First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light

Tác giả

Christoph Jakob Ackermann, Martin Reck, Luis Paz-Ares, Fabrice Barlesi, Raffaele Califano.

6. Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study

Tác giả

Lisheng Xu, Qian Qi, Yan Zhang, Jiadong Cui, Yu Li.

6. Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial

Tác giả

Marco Platania, Felice Pasini, Luca Porcu, Mattia Boeri, Filippo de Braud.

6. Predictive value of a prognostic model based on pathologic features in lung invasive adenocarcinoma

Tác giả

Ao Liu, Feng Hou, Yi Qin, Guisong Song, Wenjie Jiao.

6. Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer

Tác giả

Sha Zhao, Guanghui Gao, Wei Li, Xuefei Li, Caicun Zhou.

6. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Tác giả

Samuel P. Heilbroner, Eric P. Xanthopoulos, Donna Buono, Yongmei Huang, Simon K. Cheng.

6. Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing

Tác giả

Hidenori Mizugaki, Akinobu Hamada, Tatsuhiro Shibata, Fumie Hosoda, Yutaka Fujiwara.

6. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer

Tác giả

Ya-Lan Wu, Qian Zhao, Lei Deng, Yan Zhang, Yong-Mei Liu.

7. Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience

Tác giả

Marco Chiappetta, Edoardo Zanfrini, Luca Giraldi, Maria Giovanna Mastromarino, Stefano Margaritora.

7. Survival in patients with malignant pleural effusion undergoing talc pleurodesis

Tác giả

Maged Hassan, Rachel M Mercer, Nick A Maskell, Rachelle Asciak, Najib M Rahman.

7. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients

Tác giả

Zhengbo Song, Wenxian Wang, Min Li, Junjun Liu, Yiping Zhang.

7. Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation

Tác giả

J. Nicholas Bodor, Josephine L. Feliciano, Martin J. Edelman.

7. Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer

Tác giả

Barbara Melosky, Rosalyn Juergens, Deanna McLeod, Natasha Leighl, Quincy Chu.

7. Real-world lung cancer screening decision-making: Barriers and facilitators

Tác giả

Margaret Lowenstein, Maya Vijayaraghavan, Nancy J. Burke, Leah Karliner, Celia P. Kaplan.

7. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology

Tác giả

Wenting Tu, Guangyuan Sun, Li Fan, Yun Wang, Zhaobin Li.

7. Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos

Tác giả

Patrick Maisonneuve, Cristiano Rampinelli, Raffaella Bertolotti, Alessandro Misotti, Giulia Veronesi.

7. Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study

Tác giả

Yi-Long Wu, Caicun Zhou, Shun Lu, Shukui Qin, Guoliang Jiang.

7. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study

Tác giả

Hironori Ishida, Yoshihiko Shimizu, Hirozo Sakaguchi, Hiroyuki Nitanda, Kunihiko Kobayashi.

7. Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy

Tác giả

Kazuki Takada, Kenichi Kohashi, Mototsugu Shimokawa, Akira Haro, Yoshihiko Maehara.

7. Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial)

Tác giả

Travis Dotson, Christina Bellinger, Jing Su, Kris Hansen, Jimmy Ruiz.

8. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden

Tác giả

Tomoyuki Naito, Hibiki Udagawa, Shigeki Umemura, Tetsuya Sakai, Koichi Goto.

8. Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC

Tác giả

Taylor Leroy, Elisabeth Monnet, Stéphane Guerzider, Pascale Jacoulet, Virginie Westeel.

8. Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy

Tác giả

Eun-Ah Choe, Yoon Jin Cha, Jae-Hwan Kim, Kyoung Ho Pyo, Hye Ryun Kim.

8. Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Tác giả

Ippokratis Messaritakis, Michalis Nikolaou, Fillipos Koinis, Eleni Politaki, Athanasios Kotsakis.

8. Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer

Tác giả

Hideki Hayashi, Hirotoshi Iihara, Chiemi Hirose, Yoshihisa Fukuda, Tadashi Sugiyama.

8. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

Tác giả

Abdullah Sakin, Suleyman Sahin, Nurgul Yasar, Cumhur Demir, Sener Cihan.

8. Clinical features and outcomes of pulmonary lymphoma: A single center experience of 180 cases

Tác giả

Mu-Chen Zhang, Min Zhou, Qi Song, Shuo Wang, Wei-Li Zhao.

8. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study

Tác giả

Linda Willén, Anders Berglund, Stefan Bergström, Michael Bergqvist, Mats Lambe.

8. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells

Tác giả

Elumalai Perumal, Kim So Youn, Shin Sun, Jung Seung-Hyun, Chung Yeun-Jun.

8. Hospital lung surgery volume and patient outcomes

Tác giả

A.A. Thai, E. Stuart, L. te Marvelde, R.L. Milne, P. Mitchell.

8. Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M

Tác giả

Sha Zhao, Xuefei Li, Chao Zhao, Tao Jiang, Caicun Zhou.

8. Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer

Tác giả

Yongfeng Yu, Qiuxiang Ou, Xue Wu, Hairong Bao, Shun Lu.

9. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options

Tác giả

Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, Nikolaj Frost, Maximilian von Laffert.

9. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer

Tác giả

Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka, Mitsuaki Ishida, Yataro Daigo.

9. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter

Tác giả

Wei Li, Fei Zhou, Ziwei Wan, Meiling Li, Jingyun Shi.

9. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity

Tác giả

Satoshi Koezuka, Tetuo Mikami, Naobumi Tochigi, Atsushi Sano, Akira Iyoda.

9. Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma

Tác giả

Sehhoon Park, Joon Ho Shim, Boram Lee, Inju Cho, Jong-Mu Sun.

9. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCT

Tác giả

Barbara Melosky, Penelope Bradbury, Dongsheng Tu, Marie Florescu, Lesley Seymour.

9. Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors

Tác giả

Shaohua Cui, Yiqian Ni, Yizhuo Zhao, Zonghai Li, Liyan Jiang.

9. Understanding patients’ values and preferences regarding early stage lung cancer treatment decision making

Tác giả

Donald R. Sullivan, Karen B. Eden, Nathan F. Dieckmann, Sara E. Golden, Christopher G. Slatore.

9. High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes

Tác giả

Tamkin Ahmadzada, Kenneth Lee, Candice Clarke, Wendy A Cooper, Steven Kao.

9. Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis on the basis of stage and genetic alterations

Tác giả

Bumhee Yang, Hyun Lee, Sang-Won Um, Kyunga Kim, Hojoong Kim.

9. Static lung hyperinflation is an independent risk factor for lung cancer in patients with chronic obstructive pulmonary disease

Tác giả

Ester Zamarrón, Eva Prats, Elena Tejero, Paloma Pardo, Francisco García-Río.

9. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients

Tác giả

Jeffrey C. Thompson, Ryan Fan, Taylor Black, Gordon H. Yu, Erica L. Carpenter.

10. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy

Tác giả

Chia-I Shen, Hsu-Ching Huang, Chi-Lu Chiang, Yung-Hung Luo, Chao-Hua Chiu.

10. Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma

Tác giả

Masayuki Takeda, Yuichiro Ohe, Hidehito Horinouchi, Toyoaki Hida, Kazuhiko Nakagawa.

10. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Tác giả

Fumihiro Shoji, Hiroaki Takeoka, Yuka Kozuma, Gouji Toyokawa, Sadanori Takeo.

10. A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer

Tác giả

Jia Guo, Xiaohong Wang, Ying Wang, Liying Wang, Shucheng Hua.

10. Misclassification of the actual causes of death and its impact on analysis: A case study in non-small cell lung cancer

Tác giả

Kay See Tan.

10. Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Tác giả

Alessandro Morabito, Maria Carmela Piccirillo, Paolo Maione, Andrea Luciani, Cesare Gridelli.

10. Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Tác giả

Eiki Ichihara, Katsuyuki Hotta, Kiichiro Ninomiya, Toshio Kubo, Katsuyuki Kiura.

10. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer

Tác giả

Chen Lin, Xun Shi, Shao Yang, Jun Zhao, Xinmin Yu.

10. Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Tác giả

Haixia Li, Chenyu Wang, Ziqi Wang, Yabo Hu, Huijuan Wang.

10. Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

Tác giả

Lucio Crinò, Giuseppe Bronte, Paolo Bidoli, Paola Cravero, Angelo Delmonte.

10. Prognostic value of preoperative exercise capacity in patients undergoing thoracoscopic lobectomy for non-small cell lung cancer

Tác giả

Kazumi Hamada, Masataka Irie, Yoshihisa Fujino, Masahiro Hyodo, Takeshi Hanagiri.

10. High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients

Tác giả

Kuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, Kun-Chieh Chen, Gee-Chen Chang.

11. Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti–PD-1 therapy

Tác giả

Yuki Ikematsu, Kentaro Tanaka, Toyoshi Yanagihara, Renpeng Liu, Isamu Okamoto.

11. Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies

Tác giả

Jessica A. Hellyer, Matthew A. Gubens, Kristen M. Cunanan, Sukhmani K. Padda, Patrick J. Loehrer.

11. A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer

Tác giả

Liza C. Villaruz, Manuel Cobo, Konstantinos Syrigos, Dimitrios Mavroudis, Mark A. Socinski.

11. Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma

Tác giả

Francesco Morra, Francesco Merolla, Debora D’Abbiero, Gennaro Ilardi, Angela Celetti.

11. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands

Tác giả

M. van de Ven, V.P. Retèl, H. Koffijberg, W.H. van Harten, M.J. IJzerman.

11. c-MET as a biomarker in patients with surgically resected non-small cell lung cancer

Tác giả

Georgios Tsakonas, Johan Botling, Patrick Micke, Chris Rivard, Simon Ekman.

11. Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

Tác giả

Sandra Assoun, Nathalie Theou-Anton, Marina Nguenang, Aurélie Cazes, Gérard Zalcman.

11. Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017

Tác giả

Natsuki Takano, Ryo Ariyasu, Junji Koyama, Tomoaki Sonoda, Makoto Nishio.

11. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11

Tác giả

Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, Anders Berglund, Johan Botling.

11. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data

Tác giả

Young Wha Koh, Su Jin Lee, Jae-Ho Han, Seokjin Haam, Hyun Woo Lee.

11. Nut and peanut butter consumption and the risk of lung cancer and its subtypes: A prospective cohort study

Tác giả

Lisette Nieuwenhuis, Piet A. van den Brandt.

11. Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

Tác giả

Christos Chouaid, Lionel Bensimon, Emilie Clay, Aurélie Millier, Pierre Levy.

12. A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)

Tác giả

Hajime Asahina, Satoshi Oizumi, Kei Takamura, Toshiyuki Harada, Masaharu Nishimura.

12. Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy

Tác giả

Min-Shu Hsieh, Mong-Wei Lin, Yi-Hsuan Lee.

12. Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma

Tác giả

Tomohiro Ichikawa, Keiju Aokage, Tomohiro Miyoshi, Kenta Tane, Genichiro Ishii.

12. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial

Tác giả

Dong-Wan Kim, Dae Ho Lee, Ji-Youn Han, Jongseok Lee, Keunchil Park.

12. Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer

Tác giả

Jessica A. Hellyer, Henning Stehr, Millie Das, Sukhmani K. Padda, Heather A. Wakelee.

12. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients

Tác giả

Xiao Li, Chao Zhang, Zewen Sun, Fan Yang, Jun Wang.

12. Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer

Tác giả

Giulia Galli, Tiziana Triulzi, Claudia Proto, Diego Signorelli, Giuseppe Lo Russo.

12. From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Tác giả

Paola Bordi, Marzia Del Re, Roberta Minari, Eleonora Rofi, Marcello Tiseo.

12. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H

Tác giả

Matthew A. Gubens, Lecia V. Sequist, James P. Stevenson, Steven F. Powell, Leena Gandhi.

12. Diagnosing a solitary pulmonary nodule using multiple bronchoscopic guided technologies: A prospective randomized study

Tác giả

Liyan Bo, Congcong Li, Lei Pan, Hongwu Wang, Faguang Jin.

12. Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study

Tác giả

Majken M. Brønserud, Maria Iachina, Anders Green, Mogens Groenvold, Erik Jakobsen.

12. Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy

Tác giả

Anna D. Coutinho, Manan Shah, Orsolya E. Lunacsek, Michael Eaddy, Joanne P. Willey.

13. Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors

Tác giả

Donella Puliti, Mario Mascalchi, Francesca Maria Carozzi, Laura Carrozzi, Marco Zappa.

13. Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice

Tác giả

Yijun Jia, Sha Zhao, Tao Jiang, Xuefei Li, Caicun Zhou.

13. An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

Tác giả

Daniel Morgensztern, Nina Karaseva, Enriqueta Felip, Ignacio Delgado, Pilar Garrido.

13. Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors

Tác giả

Hao Xie, Jennifer M. Boland, Joseph J. Maleszewski, Marie Christine Aubry, Anja C. Roden.

13. A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

Tác giả

Ji Soo Park, Min Hee Hong, You Jin Chun, Hye Ryun Kim, Byoung Chul Cho.

13. MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells

Tác giả

Makoto Tada, Toshiyuki Sumi, Yusuke Tanaka, Sachie Hirai, Yuji Sakuma.

13. The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis

Tác giả

Chong Hyun Suh, Kyung Won Kim, Junhee Pyo, Hiroto Hatabu, Mizuki Nishino.

13. The role of adjuvant therapy for atypical bronchopulmonary carcinoids

Tác giả

Rodney E. Wegner, Stephen Abel, Shaakir Hasan, Zachary D. Horne, Vivek Verma.

13. Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study

Tác giả

Oscar Arrieta, Feliciano Barrón, Federico Maldonado, Luis Cabrera, Jaime De la Garza.

13. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

Tác giả

Satoshi Watanabe, Hiroshige Yoshioka, Hiroshi Sakai, Katsuyuki Hotta, Tomohide Tamura.

13. Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer

Tác giả

Leora Horn, Joshua Bauml, Patrick M. Forde, Keith L. Davis, Bruce E. Johnson.

13. Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negative for EGFR mutation and ALK fusion

Tác giả

Hitomi Sakai, Masayuki Takeda, Kazuko Sakai, Yasushi Nakamura, Kazuhiko Nakagawa.

14. Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer

Tác giả

Maurice Pérol, Nick Pavlakis, Evgeny Levchenko, Marco Platania, Solange Peters.

14. Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: A pilot study

Tác giả

Vivek Murthy, Daniel P. Katzman, Jun-Chieh J. Tsay, Jamie L. Bessich, Daniel H. Sterman.

14. Galectin-9 in non-small cell lung cancer

Tác giả

Yayi He, Keyi Jia, Rafal Dziadziuszko, Sha Zhao, Caicun Zhou.

14. Airflow limitation and survival after surgery for non-small cell lung cancer: Results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study)

Tác giả

R.J. Hopkins, J. Ko, G.D. Gamble, R.P. Young.

14. Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysis

Tác giả

Jelle E. Bousema, Martijn van Dorp, Fieke Hoeijmakers, Ilse A. Huijbregts, Frank J.C. van den Broek.

14. Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis

Tác giả

Mark M. Awad, Giulia C. Leonardi, Sasha Kravets, Suzanne E. Dahlberg, Rebecca S. Heist.

14. Demography, patterns of care and survival outcomes in patients with malignant tumors of trachea: A systematic review and individual patient data analysis of 733 patients

Tác giả

Supriya Mallick, Rony Benson, Prashanth Giridhar, Angel Rajan Singh, Goura K Rath.

14. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

Tác giả

Keith M. Kerr, Erik Thunnissen, Urania Dafni, Stephen P. Finn, Rolf Stahel.

14. Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors

Tác giả

Tao Jiang, Yuchen Bai, Fei Zhou, Wei Li, Caicun Zhou.

14. Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer

Tác giả

Ivo Überall, Mariam Gachechiladze, Markus Joerger, Josef Anděl, Josef Škarda.

14. Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey

Tác giả

Ju-Fang Shi, Le Wang, Ning Wu, Jun-Ling Li, Min Dai.

14. Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer

Tác giả

Waqar Haque, Vivek Verma, E. Brian Butler, Bin S. Teh, Chad G. Rusthoven.

15. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

Tác giả

Longjiang She, Huabin Hu, Mengting Liao, Xuefeng Xia, David P. Carbone.

15. First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma

Tác giả

Zuan Lin, Sha Fu, Yixin Zhou, Xuanye Zhang, Shaodong Hong.

15. EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Tác giả

Hisao Higo, Kadoaki Ohashi, Go Makimoto, Kazuya Nishii, Katsuyuki Kiura.

15. Clinical significance of ROS1 5’ deletions in non-small cell lung cancer

Tác giả

Elisa Capizzi, Filippo Gustavo Dall’Olio, Elisa Gruppioni, Francesca Sperandi, Andrea Ardizzoni.

15. Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC-A retrospective cohort study

Tác giả

David Lang, Andreas Horner, Elmar Brehm, Kaveh Akbari, Bernd Lamprecht.

15. Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations

Tác giả

Sheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, Jin-Yuan Shih.

15. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma

Tác giả

Ian Berger, Keith A. Cengel, Charles B. Simone, Evan W. Alley, Sharyn I. Katz.

15. Significance of Tsukushi in lung cancer

Tác giả

Tatsuya Yamada, Kunimasa Ohta, Yamato Motooka, Kosuke Fujino, Takaaki Ito.

15. Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer

Tác giả

Kangkook Lee, Youjin Kim, Hyun Ae Jung, Se-Hoon Lee, Jong-Mu Sun.

15. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study

Tác giả

Zewen Sun, Xizhao Sui, Fan Yang, Jun Wang.

15. Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study

Tác giả

Shirish M. Gadgeel, Rimas V. Lukas, Jerome Goldschmidt, Paul Conkling, Lou Fehrenbacher.

15. Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China

Tác giả

Xiaohua Gu, Qiang Zhang, Yun-Bo Chu, Yi-Yang Zhao, Bin Wu.

16. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis

Tác giả

F. Eichhorn, L.V. Klotz, T. Muley, S. Kobinger, M.E. Eichhorn.

16. Consolidation-to-tumor ratio and tumor disappearance ratio are not independent prognostic factors for the patients with resected lung adenocarcinomas

Tác giả

Hyungjin Kim, Jin Mo Goo, Young Tae Kim, Chang Min Park.

16. Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Tác giả

Renaud Descourt, Maurice Perol, Gaëlle Rousseau-Bussac, David Planchard, Christos Chouaid.

16. Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients

Tác giả

Johanne Andersen Hojbjerg, Eva Boysen Fynboe Ebert, Michelle Simone Clement, Anne Winther-Larsen, Boe Sorensen.

16. Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme

Tác giả

Bhagabati Ghimire, Roberta Maroni, Daniel Vulkan, Zoheb Shah, John K. Field.

16. Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice

Tác giả

Doran Ksienski, Elaine S. Wai, Nicole Croteau, Ashley T. Freeman, Mary Lesperance.

16. The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP

Tác giả

Jung Ki Yoo, Ji Min Lee, Seung Hee Kang, Seong Ho Jeon, Jin Kyeoung Kim.

16. FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective

Tác giả

Alvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Patricia Yagüe, Ángela Marrugal, Luis Paz-Ares.

16. Pathologic nodal clearance and complete response following neoadjuvant chemoradiation for clinical N2 non-small cell lung cancer: Predictors and long-term outcomes

Tác giả

Waqar Haque, Vivek Verma, E. Brian Butler, Bin S. Teh.

16. Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report

Tác giả

Ilke Tunali, Jhanelle E. Gray, Jin Qi, Mahmoud Abdalah, Matthew B. Schabath.

16. The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancer

Tác giả

Kentaro Ito, Satoru Miura, Tadashi Sakaguchi, Kenta Murotani, Nobuyuki Yamamoto.

16. Association of oral health with lung cancer risk in a low-income population of African Americans and European Americans in the Southeastern United States

Tác giả

Hyung-Suk Yoon, Wanqing Wen, Jirong Long, Wei Zheng, Qiuyin Cai.

17. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Tác giả

B.C.M. Hermans, J.L. Derks, E. Thunnissen, R.J. van Suylen, A.M.C. Dingemans.

17. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung

Tác giả

Moonsik Kim, Yeon Seung Chung, Kyoung A Kim, Hyo Sup Shim.

17. Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients

Tác giả

Dong Woog Yoon, Dong Wook Shin, Jong Ho Cho, Jeong Hoon Yang, Sang Hyun Park.

17. Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis

Tác giả

Ian Fraser, Shilo Lefresne, Jacqueline Regan, Eric Berthelet, Robert Olson.

17. Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Tác giả

Jon Zugazagoitia, Ana Gómez-Rueda, Eloisa Jantus-Lewintre, Dolores Isla, Pilar Garrido.

17. Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer

Tác giả

Laura Romero-Vielva, Santiago Viteri, Irene Moya-Horno, José Ignacio Toscas, Rafael Rosell.

17. Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab

Tác giả

Jun Oyanagi, Yasuhiro Koh, Koichi Sato, Keita Mori, Nobuyuki Yamamoto.

17. Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017

Tác giả

Mickaël Lattuca-Truc, Jean-François Timsit, Matteo Giaj Levra, Stéphane Ruckly, Anne-Claire Toffart.

17. The distress thermometer as a prognostic tool for one-year survival among patients with lung cancer

Tác giả

O.P. Geerse, D. Brandenbarg, H.A.M. Kerstjens, A.J. Berendsen, T.J.N. Hiltermann.

17. Imaging characteristics of BRAF-mutant non-small cell lung cancer by functional class

Tác giả

Dexter P. Mendoza, Ibiayi Dagogo-Jack, Tianqi Chen, Atul Padole, Subba Rao Digumarthy.

17. Chest radiography surveillance for lung cancer: Results from a National Health Insurance database in South Korea

Tác giả

Hyun Jung Koo, Chang-Min Choi, Sojung Park, Han Na Lee, Mi Young Kim.

17. Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation

Tác giả

Jean Bernard Auliac, Maurice Pérol, David Planchard, Isabelle Monnet, Christos Chouaid.

18. Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer

Tác giả

Jair Bar, Efrat Ofek, Iris Barshack, Teodor Gottfried, Amir Onn.

18. A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer

Tác giả

Benjamin Besse, Fabrice Barlesi, Ingel Demedts, Jose Fuentes Pradera, Johan Vansteenkiste.

18. A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer

Tác giả

Yu-Jung Kim, Bhumsuk Keam, Chan-Young Ock, Sanghoon Song, Dae Seog Heo.

18. Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer

Tác giả

Zorawar S. Noor, Jonathan W. Goldman, William E. Lawler, Bijoy Telivala, Edward B. Garon.

18. Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

Tác giả

Alexander Haragan, John K. Field, Michael P.A. Davies, Carles Escriu, John R. Gosney.

18. Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting ‘Direct to LAT’ in selected groups

Tác giả

Selina Tsim, Sarah Paterson, Douglas Cartwright, Christopher J. Fong, Kevin G. Blyth.

18. Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening

Tác giả

Fei Liang, Chunxiao Wu, Haiyan Gu, Meiying Zhu, Ying Zheng.

18. Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)

Tác giả

Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, Daichi Fujimoto, Kazuhiko Nakagawa.

18. Correlation study between dual source CT perfusion imaging and the microvascular composition of solitary pulmonary nodules

Tác giả

Meng Wang, Bangguo Li, Hui Sun, Tingting Huang, Xianli Luo.

18. Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinib

Tác giả

Xuanxuan Zheng, Guowei Zhang, Peng Li, Mina Zhang, Huijuan Wang.

18. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma

Tác giả

Stephen Abel, Shaakir Hasan, Richard White, Lana Schumacher, Rodney E. Wegner.

18. Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)

Tác giả

Balazs Halmos, Eng-Huat Tan, Ross A. Soo, Jacques Cadranel, Enric Carcereny.

19. Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease

Tác giả

Na Zhou, Yi Lin, Xianghong Peng, Yingyi Wang, Yuzhou Wang.

19. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification

Tác giả

Joji Samejima, Tomoyuki Yokose, Hiroyuki Ito, Haruhiko Nakayama, Munetaka Masuda.

19. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation

Tác giả

Jing Jin, Yuncui Gan, Huayong Liu, Zirong Wang, Weimin Li.

19. Lung cancers associated with cystic airspaces: CT features and pathologic correlation

Tác giả

Yingran Shen, Xinnan Xu, Yunfei Zhang, Weitong Li, Gening Jiang.

19. Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells

Tác giả

Hiroshi Nakamura, Masato Sugano, Tomoyuki Miyashita, Hiroko Hashimoto, Genichiro Ishii.

19. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Tác giả

J.H.R.J. Degens, K.J.C. Sanders, E.E.C. de Jong, H.J.M. Groen, A.-M.C. Dingemans.

19. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC)

Tác giả

Giuseppe Minniti, Claudia Scaringi, Gaetano Lanzetta, Dimitri Anzellini, Sergio Paolini.

19. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases

Tác giả

Kai Yin, Yang-Si Li, Mei-Mei Zheng, Ben-Yuan Jiang, Xu-Chao Zhang.

19. Capitalizing on a teachable moment: Development of a targeted self-help smoking cessation intervention for patients receiving lung cancer screening

Tác giả

Lauren R. Meltzer, Marina Unrod, Vani N. Simmons, Karen O. Brandon, Thomas H. Brandon.

19. Identification of a novel WNK1–ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib

Tác giả

Yutao Liu, Tianfeng Liu, Nan Li, Tao Wang, Rui Lin.

19. Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progression

Tác giả

José Luis Cedillo, Anna Bordas, Francisco Arnalich, Isabel Esteban-Rodríguez, Carmen Montiel.

19. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models

Tác giả

Kyoung Ho Pyo, Jae Hwan Kim, Ji-Min Lee, Sung Eun Kim, Byoung Chul Cho.

20. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma

Tác giả

Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp, Hiroshi Nokihara, Tomohide Tamura.

20. Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Tác giả

Camille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, Roger Lacave, Etienne Giroux Leprieur.

20. PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer

Tác giả

Ryota Sumitomo, Tatsuya Hirai, Masaaki Fujita, Hiroaki Murakami, Cheng-long Huang.

20. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung

Tác giả

Shuhang Wang, Hanxiao Chen, Jia Zhong, Haifeng Qin, Jie Wang.

20. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer

Tác giả

Bin Zhang, Xueliang Niu, Qiang Zhang, Chunli Wang, ... Weiran Liu.

20. Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio

Tác giả

Ashwin Shinde, Zachary D. Horne, Richard Li, Scott Glaser, Arya Amini.

20. Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells

Tác giả

Johan Vad-Nielsen, Kristine Raaby Gammelgaard, Tina Fuglsang Daugaard, Anders Lade Nielsen.

20. Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma

Tác giả

Sun Min Lim, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hye Ryun Kim.

20. Nivolumab-refractory patients with advanced non-small-cell lung cancer

Tác giả

A. Costantini, V. Fallet, J. Corny, S. Friard, J. Cadranel.

20. Primary pulmonary collision tumor comprising squamous cell carcinoma and mucosa-associated lymphoid tissue lymphoma

Tác giả

Masahiro Yamasaki, Tomoyoshi Takenaka, Naoko Matsumoto, Hideki Asaoku, Noboru Hattori.

20. Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer

Tác giả

Matthew J. Schuchert, Daniel P. Normolle, Omar Awais, Arjun Pennathur, Rodney J. Landreneau.

20. Assessing the lung cancer comorbidome: An analysis of German claims data

Tác giả

Monika Murawski, Julia Walter, Larissa Schwarzkopf.

21. The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors

Tác giả

Janakiraman Subramanian, Ancilla W. Fernandes, François Laliberté, Melissa Pavilack, Mei Sheng Duh.

21. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer

Tác giả

Giulia Galli, Alessandro De Toma, Filippo Pagani, Giovanni Randon, Giuseppe Lo Russo.

21. Cost-effectiveness analysis of pembrolizumab monotherapy and chemotherapy in the non-small-cell lung cancer with different PD-L1 tumor proportion scores

Tác giả

Kexun Zhou, Chenlu Jiang, Qiu Li.

21. Searching for selected VOCs in human breath samples as potential markers of lung cancer

Tác giả

Joanna Rudnicka, Tomasz Kowalkowski, Bogusław Buszewski.

21. Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

Tác giả

Antonio Santo, Sara Pilotto, Domenico Galetta, Francesco Grossi, Emilio Bria.

21. Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes

Tác giả

Jacqueline V. Aredo, Sukhmani K. Padda, Christian A. Kunder, Summer S. Han, Heather A. Wakelee.

21. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence

Tác giả

V. Grøndahl, T. Binderup, S.W. Langer, R.H. Petersen, U. Knigge.

21. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer

Tác giả

Sherry X. Yan, Muhammad M. Qureshi, Michael Dyer, Minh Tam Truong, Kimberley S. Mak.

21. A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy

Tác giả

Haiyue Wang, Leina Sun, Yaxiong Sang, Xin Yang, Dongmei Lin.

21. Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer

Tác giả

Yi-Tsz Lin, Chia-Yu Chu.

21. Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer

Tác giả

Akira Ono, Mitsuhiro Isaka, Masakuni Serizawa, Katsuhiro Omae, Yasuhisa Ohde.

21. Variable impact of prior cancer history on the survival of lung cancer patients

Tác giả

Andres F. Monsalve, Jessica R. Hoag, Benjamin J. Resio, Alexander S. Chiu, Daniel J. Boffa.

22. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study

Tác giả

W.A. Buikhuisen, F. Qayyum, S.G. Armato, P. Baas.

22. Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization

Tác giả

Luna Kadouri, Yakir Rottenberg, Aviad Zick, Tamar Hamburger, Hovav Nechushtan.

22. Performance of community-based lung cancer screening program in a Histoplasma endemic region

Tác giả

Shruti Bhandari, Prashant Tripathi, Danh Pham, Christina Pinkston, Goetz Kloecker.

22. Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer

Tác giả

Li Zhang, Dan Pu, Dan Liu, Ye Wang, Weimin Li

22. Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study

Tác giả

Amanda J.W. Gibson, Haocheng Li, Adrijana D’Silva, Anifat A. Elegbede, Winson Y. Cheung.

22. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial

Tác giả

S. Peters, E. Felip, U. Dafni, C. Belka, D. De Ruysscher.

22. The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma

Tác giả

H. Wang, J. Agulnik, G. Kasymjanova, P.O. Fiset, A. Spatz.

22. Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling

Tác giả

Shawn J. Rice, Xin Liu, Jianhong Zhang, Bei Jia, Chandra P. Belani.

22. Patient reported outcome data as performance indicators in surgically treated lung cancer patients

Tác giả

Majken M. Brønserud, Maria Iachina, Anders Green, Mogens Groenvold, Erik Jakobsen.

22. Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab

Tác giả

Charlotte Mauclet, Fabrice Duplaquet, Lionel Pirard, Benoît Rondelet, Sebahat Ocak.

22. Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations

Tác giả

Hanako Hasegawa, Hiroyuki Yasuda, Junko Hamamoto, Keita Masuzawa, Kenzo Soejima.

23. Erratum to “Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/G and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib” [Lung Cancer, 108 (June 2017) 228-231]

Tác giả

Sai-Hong Ignatius Ou, Jean Cui, Alexa B. Schrock, Michael E. Goldberg, Siraj M. Ali.

23. Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer

Tác giả

Akihiro Yoshimura, Tadaaki Yamada, Aya Miyagawa-Hayashino, Yuta Sonobe, Koichi Takayama.

23. Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Tác giả

Antonin Levy, Lizza E.L. Hendriks, Cécile Le Péchoux, Sally Falk, Corinne Faivre-Finn.

23. Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients

Tác giả

Fang Hu, Changhui Li, Jianlin Xu, Jindong Guo, Xueyan Zhang.

23. Evaluation of maximum standardized uptake value at fluorine-18 fluorodeoxyglucose positron emission tomography as a complementary T factor in the eighth edition of lung cancer stage classification

Tác giả

Hyungjin Kim, Jin Mo Goo, Jin Chul Paeng, Young Tae Kim, Chang Min Park.

23. Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis

Tác giả

Elisabeth Gaye, Margaux Geier, Paul Bore, Marine Guilloïque, Renaud Descourt.

23. Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

Tác giả

Keunchil Park, Jaafar Bennouna, Michael Boyer, Toyoaki Hida, Nobuyuki Yamamoto.

23. The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance

Tác giả

Grainne M. O’Kane, Geoffrey Liu, Tracy L. Stockley, Muqdas Shabir, Natasha B. Leighl.

23. Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study

Tác giả

S. Schmid, D. Klingbiel, S. Aeppli, C. Britschgi, M. Früh.

23. Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor

Tác giả

Shijie Mai, Gang Xiong, Dingwei Diao, Wenjing Wang, Ruijun Cai.

23. The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Tác giả

Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, Diana Canetti, Marcello Tiseo.

24. Erratum to “Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer” [Lung Cancer 132 (June) (2019) 154-156]

Tác giả

Shaowei Lan, Hui Li, Ying Liu, Lixia Ma, Ying Cheng.

24. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma

Tác giả

Tingting Feng, Zhongzhong Chen, Jianjun Gu, Yuxiu Wang, Lingfeng Min.

24. A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site

Tác giả

Hitomi Kawai, Masato Sugano, Noriyuki Nakano, Masafumi Muratani, Masayuki Noguchi.

24. Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

Tác giả

Hibiki Udagawa, Hiroaki Akamatsu, Kentaro Tanaka, Masayuki Takeda, Isamu Okamoto.

24. Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer

Tác giả

Myung Han Hyun, Eun Seong Lee, Jae Seon Eo, Sungeun Kim, Yeul Hong Kim.

24. Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma

Tác giả

Richard Riedel, Sebastian Michels, Carina Heydt, Janna Siemanowski, Jürgen Wolf.

24. Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events

Tác giả

Kei Kunimasa, Harumi Nakamura, Kazuko Sakai, Motohiro Tamiya, Toru Kumagai.

24. Comment on: Synchronous multiple non-small cell lung cancers in an allograft lung recipient

Tác giả

Christiaan Tji Gan, Erik Verschuuren, Wim van de Bij, Caroline Van De Wauwer, Michiel Erasmus.

24. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis

Tác giả

Corey C. Foster, Chad G. Rusthoven, David J. Sher, Lawrence Feldman, Matthew Koshy.

24. Outcomes of Stage III NSCLC with occult primary vs. known primary lesions

Tác giả

Paul B. Romesser, Yonatan Bardash, Darren Buonocore, Jamie E. Chaft, Abraham J. Wu.

25. Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S): A proof for artifact

Tác giả

Giuseppe Pelosi, Francesco Nesa, Davide Taietti, Sascia Pietro Servillo, Matteo Incarbone.

25. A case of primary lung squamous cell carcinoma mimicking malignant mesothelioma producing granulocyte colony stimulating factor with chemotherapy (cisplatin and gemcitabine)-associated thrombotic thrombocytopenic purpura (TTP); An autopsy case report

Tác giả

Yasuhito Suzuki, Kenya Kanazawa, Risa Kanai, Hikaru Tomita, Yoko Shibata.

25. Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer

Tác giả

Jordi Alcaraz, Josep Lluís Carrasco, Laura Millares, Iuliana-Cristiana Luis, Eduard Monsó.

25. Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer

Tác giả

Dwight H. Owen, Terence M. Williams, Erin M. Bertino, Xiaokui Mo, Gregory A. Otterson.

25. Challenging BRAF/EGFR co-inhibition in NSCLC using sequential liquid biopsies

Tác giả

J. Solassol, J.A. Vendrell, R. Senal, P. Audran, X. Quantin.

25. Comment on: 'Correlation of Tumor Spread through Air Spaces and Clinicopathological Characteristics in Surgically Resected Lung Adenocarcinomas'

Tác giả

Tieniu Song, Lili Jiang, Yidan Lin.

25. Response to comment on: ‘Synchronous multiple non-small cell lung cancers in an allograft lung recipient’

Tác giả

Jean-Louis Pujol, Sébastien Bommart, Pascal Pujol.

25. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target

Tác giả

Tatiana Correa Carneiro-Lobo, Luiza Coimbra Scalabrini, Leila da Silva Magalhães, Laura B. Cardeal, Daniela Sanchez Bassères.

25. Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma

Tác giả

Neelam Kumar, Doraid Alrifai, Krishna K. Kolluri, Elizabeth K. Sage, Sam M. Janes.

26. Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report

Tác giả

Guanming Jiang, Min Zhang, Qinquan Tan, Shunhuan Lin, Jianping Zhou.

26. Comment on: "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos"

Tác giả

Edward J.A. Harris, A.W. Musk, Nicholas DeKlerk, Fraser J.H. Brims.

26. Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)

Tác giả

Dolores Isla, Ramón De Las Peñas, Amelia Insa, Raquel Marsé, Mariano Provencio.

26. Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Tác giả

M. Dietel, N. Savelov, R. Salanova, P. Micke, A.C. Deitz.

26. Response to comment on: “Correlation of Tumor Spread through Air Spaces and Clinicopathological Characteristics in Surgically Resected Lung Adenocarcinomas.”

Tác giả

Min-Shu Hsieh, Mong-Wei Lin.

26. Corrigendum to “Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas” [Lung Cancer 126 (2018) 189–193]

Tác giả

Szu-Yen Hu, Min-Shu Hsieh, Hsao-Hsun Hsu, Tung-Ming Tsai, Jin-Shing Chen.

26. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Tác giả

B.C.M. Hermans, J.L. Derks, E. Thunnissen, R.J. van Suylen, A.-M.C. Dingemans.

26. Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor

Tác giả

Sehhoon Park, Joungho Han, Jong-Mu Sun.

27. Comment on the article titled “Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes”

Tác giả

Junmiao Wen, Jiayan Chen, Min Fan.

27. Comment on: “Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos”

Tác giả

Fabio Barbone, Fabiano Barbiero, Gianpiero Fasola.

27. Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough?

Tác giả

Stephen Abel, Shaakir Hasan, Vivek Verma, Benny Weksler, Rodney E. Wegner.

27. Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer

Tác giả

Norimitsu Kasahara, Kyoichi Kaira, Koichi Yamaguchi, Hiroaki Masubuchi, Takeshi Hisada.

27. What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

Tác giả

Sara Bravaccini.

27. Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia

Tác giả

Masayo Yoshimura, Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Kazuki Nabeshima.

27. Comment on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC

Tác giả

Ran Xu, Jing Zhu.

28. Response to comment on “Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes”

Tác giả

Jacqueline V. Aredo, Sukhmani K. Padda, Christian A. Kunder, Summer S. Han, Heather A. Wakelee.

28. Response to comment on: “Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos”

Tác giả

Patrick Maisonneuve, Sergio Iavicoli, Giulia Veronesi.

28. A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402)

Tác giả

Toshihide Yokoyama, Hiroshige Yoshioka, Daichi Fujimoto, Yoshiki Demura, Toyohiro Hirai.

28. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study

Tác giả

P.N. Ding, T.M. Becker, V.J. Bray, W. Chua, T.L. Roberts.

28. Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer

Tác giả

Shaowei Lan, Hui Li, Ying Liu, Lixia Ma, Ying Cheng.

28. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung

Tác giả

Thomas Muley, Ying He, Vinzent Rolny, Birgit Wehnl, Farshid Dayyani.

28. Reply to the comments on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NS

Tác giả

Chong Hyun Suh, Kyung Won Kim, Mizuki Nishino.

29. Primary resistance to icotinib in a patient with lung adenocarcinoma harboring EGFR L858R and Q787k mutations

Tác giả

Wei Heng, Chuanyun You, Cai Shangli, Qi Chuang, Xiao Mingzhe.

29. Impact of health care organization on surgical lung cancer care

Tác giả

D.J. Heineman, F. Hoeijmakers, N. Beck, C. Dickhoff, E. Jakobsen.

29. The expanding role of endobronchial ultrasound in patients with centrally located intrapulmonary tumors

Tác giả

J.C. Kuijvenhoven, V. Livi, L. Morandi, A. Cancellieri, R. Trisolini.

29. Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung C

Tác giả

Satoshi Watanabe, Hiroshige Yoshioka, Hiroshi Sakai, Katsuyuki Hotta, Tomohide Tamura.

29. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control?

Tác giả

Qingwei Luo, Julia Steinberg, Dianne L. O’Connell, Xue Qin Yu, Karen Canfell.

29. Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations

Tác giả

Ichidai Tanaka, Masahiro Morise, Yuta Kodama, Akira Matsui, Yoshinori Hasegawa.

30. Erratum to “Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases” [Lung Cancer 116 (February 2018) 62–66]

Tác giả

Clément Gauvain, Enora Vauléon, Christos Chouaid, Emilie Le Rhun, Isabelle Monnet.

30. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

Tác giả

Kaname Nosaki, Hideo Saka, Yukio Hosomi, Paul Baas, Gilberto Lopes.

30. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites

Tác giả

Katsuhiro Yoshimura, Yusuke Inoue, Masato Karayama, Kazuo Tsuchiya, Haruhiko Sugimura.

30. Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April) (2019) 162–168]

Tác giả

Corey C. Foster, Chad G. Rusthoven, David J. Sher, Lawrence Feldman, Matthew Koshy.

30. Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study

Tác giả

Claus-Christoph Steffens, Corinna Elender, Ulrich Hutzschenreuter, Stephanie Dille, Norbert Marschner.

31. Erratum to “High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors” [Lung Cancer 132 (June) (2019) 9-16]

Tác giả

Guk Jin Lee, Heejung Lee, In Sook Woo, Taejung Kim, Jin-Hyoung Kang.

31. Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis

Tác giả

Frank Griesinger, Ellen E. Korol, Sheena Kayaniyil, Nebibe Varol, Sarah M. Goring.

31. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Tác giả

Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, Rita Chiari, Silvia Novello.

31. Corrigendum to “Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]

Tác giả

Makoto Nishio, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Tomohide Tamura.

31. Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer

Tác giả

Kexun Zhou, Jing Zhou, Jiaxing Huang, Nan Zhang, Qiu Li.

32. Erratum to “The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma” [Lung Cancer 132 (June) (2019) 36–38]

Tác giả

H. Wang, J. Agulnik, G. Kasymjanova, P.O. Fiset, A. Spatz.

32. Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis

Tác giả

Christopher J. Cadham, Jinani C. Jayasekera, Shailesh M. Advani, Shelby J. Fallon, Jeanne S. Mandelblatt.

32. The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer

Tác giả

Zhichao Liu, Hengrui Liang, Jie Lin, Xiuyu Cai, Wenhua Liang.

32. The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment

Tác giả

Yoshihiko Sakata, Kodai Kawamura, Kazuya Ichikado, Naoki Shingu, Takuro Sakagami.

33. Corrigendum to “Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features” [Lung Cancer 135 (September) (2019) 1-9]

Tác giả

Mohammadhadi Khorrami, Prantesh Jain, Kaustav Bera, Mehdi Alilou, Anant Madabhushi.

33. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

Tác giả

Sarah-Louise Ryan, Sam Beard, Martin P. Barr, Kazou Umezawa, Anne-Marie Baird.

33. Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients

Tác giả

Ilaria Francaviglia, Gilda Magliacane, Chiara Lazzari, Greta Grassini, Maria Giulia Cangi.

33. MET Y1003S point mutation shows sensitivity to crizotinib in a patient with lung adenocarcinoma

Tác giả

Yun L. Miao, Qing Qing Xu.

34. Corrigendum to “Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation” [Lung Cancer 135 (September) (2019) 16-20]

Tác giả

J. Nicholas Bodor, Josephine L. Feliciano, Martin J. Edelman.

34. Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas

Tác giả

A. Guirao, L. Molins, I. Ramón, G. Sunyer, A. Agustí.

34. Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes

Tác giả

Qifeng Ding, Donglai Chen, Xiaofan Wang, Junmiao Wen, Yongbing Chen.

34. Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

Tác giả

N. de Rouw, S. Croes, R. Posthuma, D.E. Agterhuis, R. ter Heine.

35. Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137-141]

Tác giả

Hossein Maymani, Kenneth Hess, Roman Groisberg, David S. Hong, Vivek Subbiah.

35. Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Tác giả

Thomopoulou Konstantina, Rounis Konstantinos, Koutsopoulos Anastasios, Mala Anastasia, Mavroudis Dimitris.

35. UPSTAGING, CENTRALITY AND SURVIVAL IN EARLY STAGE NON-SMALL CELL LUNG CANCER VIDEO-ASSISTED SURGERY

Tác giả

M. Boada, R. Guzmán, M. Montesinos, A. Libreros, L. Molins.

35. Corrigendum to “Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer” [Lung Cancer 128 (2019) 152–157]

Tác giả

Akira Ono, Mitsuhiro Isaka, Masakuni Serizawa, Katsuhiro Omae, Yasuhisa Ohde.

36. Erratum to “Vasculature surrounding a nodule: A novel lung cancer biomarker” [Lung Cancer 114 (December) (2017) 38-43]

Tác giả

Xiaohua Wang, Joseph K. Leader, Renwei Wang, David Wilson, Jiantao Pu.

36. Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

Tác giả

Daichi Fujimoto, Makiko Yomota, Akimasa Sekine, Mitsunori Morita, Keisuke Tomii.

37. Erratum to “Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence” [Lung Cancer 132 (June) (2019) 141–149]

Tác giả

V. Grøndahl, T. Binderup, S.W. Langer, R.H. Petersen, U. Knigge.

37. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

Tác giả

Julianna G. Supplee, Marina S.D. Milan, Lee P. Lim, Kristy T. Potts, Cloud P. Paweletz.

38. Corrigendum to “Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study” [Lung Cancer 130 (2019) (April) 216–225]

Tác giả

Claus-Christoph Steffens, Corinna Elender, Ulrich Hutzschenreuter, Stephanie Dille, Norbert Marschner.

38. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer

Tác giả

Yariswamy Manjunath, Sathisha V. Upparahalli, Kanve N. Suvilesh, Diego M. Avella, Jussuf T. Kaifi.

39. Novel multiplex droplet digital PCR assay for scoring PD-L1 in non-small cell lung cancer biopsy specimens

Tác giả

Amanda Vannitamby, Shona Hendry, Louis Irving, Daniel Steinfort, Steven Bozinovski.

40. Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib

Tác giả

Niamh Coleman, Andrew Wotherspoon, Nadia Yousaf, Sanjay Popat.

41. Tuberous sclerosis complex: A rare etiology of multiple subsolid nodules

Tác giả

Lea Lantuéjoul, Guillaume Pontarollo, Emilie Reymond, Marie Brevet, Gilbert R Ferretti.

42. Small cell lung cancer elevates procalcitonin levels in the absence of infection

Tác giả

Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero.

43. Corrigendum to “Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos” [Lung Cancer, 131 (May) (2019) 23–30]

Tác giả

Patrick Maisonneuve, Cristiano Rampinelli, Raffaella Bertolotti, Alessandro Misotti, Giulia Veronesi.